信息搜索
信息关键字：药
  

共有5246条记录

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239] [240] [241] [242] [243] [244] [245] [246] [247] [248] [249] [250] [251] [252] [253] [254] [255] [256] [257] [258] [259] [260] [261] [262] [263]

·同济医药任命朱雷为副总经理2021年上半年公司净利253.99万2022-3-14 22:31:15
·中国医药3连板新冠治疗、新冠检测板块逆市大涨！多家公司密集提示股价异动风险2022-3-14 22:13:26
·新冠抗原自测相关概念“闻风起舞”连锁药房抗疫终端价值有望逐步体现2022-3-14 21:52:10
·南京医药发行5亿短期融资券发行利率2.22%2022-3-14 21:06:02
·新冠抗原自测，“有货”的公司排队涨停！药店与线上开始预售，适用于3类人群2022-3-14 21:05:08
·中国医药：新冠病毒治疗药物相关业务对公司近期经营业绩无重大影响2022-3-14 20:24:04
·神药价格直逼黄金，广誉远当家产品再涨价，药师：已经很久没到货了2022-3-14 20:02:33
·江中药业2022年第一季度预计净利1.8亿同比增长11%2022-3-14 19:46:51
·龙虎榜：7.77亿元抢筹复星医药外资净买5股机构净买7股2022-3-14 19:10:16
·丽珠集团：子公司克拉霉素片通过仿制药一致性评价2022-3-14 19:02:16
·诺泰生物：公司并未向日本盐野义制药提供新冠药物中间体2022-3-14 18:54:03
·广生堂：乙肝治疗创新药GST-HG141临床Ib期试验获得积极结果2022-3-14 18:08:04
·盘后机会挖掘汇总：贵州茅台重挫白酒股又成砸盘主力！A股开始“戒酒吃药”了？2022-3-14 17:14:21
·复盘50涨停股：九安医疗断板中国医药9天7板长江健康炸板2022-3-14 15:53:08
·国家药监局再批5家新冠抗原检测产品上市多个平台上线预售2022-3-14 14:12:42
·中国生物制药盐酸鲁拉西酮片获批用于治疗精神分裂症药物2022-3-14 13:59:41
·暴跌60%！刚刚，2400亿“药茅”出手了！2022-3-14 13:17:47
·电子身份概念横空出世！关注3条投资线索A股“药”不能停！中国医药9天7板2022-3-14 13:09:44
·化药领域先行者智同生物在细分领域构筑五大优势2022-3-14 12:07:00
·医药生物行业：新冠病毒抗原检测获批产业链相关企业有望显著受益2022-3-14 11:05:57

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239] [240] [241] [242] [243] [244] [245] [246] [247] [248] [249] [250] [251] [252] [253] [254] [255] [256] [257] [258] [259] [260] [261] [262] [263]